GuideStar Recognized as LSBC 2025 Company to Watch | August 28, 2025

Victoria, BC – We are thrilled to share that GuideStar Medical Devices (GuideStar) has been appointed to the Life Sciences BC 2025 Company to Watch – Recognition Honour Roll! We are honoured to receive this recognition, which celebrates emerging local companies that have made significant advancements and achievements over the past year. GuideStar’s main focus over the past year has been the commercial expansion of EpiZact, our novel epidural device. 

We will formally accept this recognition at the LSBC Awards Gala on October 2, 2025 at the Vancouver Convention Centre West. The team looks forward to celebrating our achievements, as well as fellow award recipients from the BC Life Sciences community at the event!

​​

About EpiZact
Epidurals are performed to provide anesthesia to a patient, by means of injection of medication into the epidural space. Traditionally, epidurals are performed using the “loss of resistance” technique. EpiZact is the first device developed for epidurals that is designed to stop the forward motion of the needle upon sensing a loss of resistance, providing a tactile and visual signal to the user while simultaneously stopping the needle from further advancement, potentially reducing the incidence of accidental dural puncture.

About GuideStar
GuideStar Medical Devices is a medical device company located in Victoria, BC. The Company’s flagship device, EpiZact, was designed with the intent of reducing the incidence of accidental dural punctures during epidural administration. GuideStar is committed to offering innovative solutions to unmet medical needs with a primary goal of enhancing patient safety.

Investor Contact
Mike Dolphin
CEO, GuideStar Medical Devices
info@guidestarmd.com